https://www.selleckchem.com/products/dyngo-4a.html
06, 95% CI 1.28-3.33; RR = 1.67, 95% CI 1.10-2.51; and RR = 2.08, 95% CI 1.10-3.93, respectively) without significant between-study heterogeneity for the short- and intermediate- term (I2 = 0.0% for both) and considerable heterogeneity for long-term follow-up (I2 = 81.1%). Conclusion Pre-transplant SO proved to be a risk factor after LT and was associated with two times higher mortality at short- and long- term follow-up. Since SO worsens the prognosis of patients after LT, the inclusion of body composition assessment before LT may hel
Like
Comment
Share
